-
Britain puts $10 million into study on long term effects of Covid-19
10,000 people will take part in the study
-
WHO halts hydroxychloroquine, HIV drugs in covid trials after failure to reduce death
A WHO-led trial is looking at the potential effect of Gilead’s antiviral drug remdesivir on Covid-19
-
Gilead's Covid-19 antiviral remdesivir gets conditional EU clearance
Remdesivir believed to be most effective in treating COVID-19 patients
-
China's Covid-19 complex to produce over 100m vaccine
Workshop complex in Wuhan to produce over 100 million doses of coronavirus vaccine annually, says official
-
China's Covid-19 complex to produce over 100M vaccine
Workshop complex in Wuhan to produce over 100 million doses of coronavirus vaccine annually, says official
-
1593424370-0/thumbs_b_c_952164a68616763cf9ae5ca1ebc22026-(1)1593424370-0-262x165.jpg)
China approves coronavirus drug for limited use
Potential COVID-19 vaccine can be used only on essential service workers such as military personnel
-
China to run human coronavirus vaccine trial in UAE
China is seeking to trial potential vaccines overseas because of a lack of new patients at home
-
Sanofi eyes approval of Covid-19 vaccine by first half of 2021
Company says it has the capacity to produce up to 1 billion doses a year of its recombinant vaccine
-
WHO sees 'great news' in steroid's trial results in Covid-19
The researchers shared initial insights about the results of the trial with WHO
-
How a vaccine made of mosquito spit could help stop the next epidemic
Manning, a clinical researcher believes she could use pieces of mosquito saliva protein to build a universal vaccine
Recent Contributors
-
Shrouq Tariq
The writer is an Egyptian researcher with a special interest in Middle Eastern Issues
-
Nasar Qadir
The writer is an economics and political science graduate, and founder of the educational initiative Averroes
-
Muhammad Hassan Majeed
The writer is a psychiatrist. He is a fellow at the department of anesthesiology and critical care management at Johns Hopkins Hospital, Baltimore, Maryland, United States.
-
Shuja Uddin
-
Ali Hasnain Rizvi The writer is a technology expert with more than 20 years of experience. Has worked for Intel, SAP, Audi and other multinationals worldwide. Since 2014, he is leading a German government led Smart City Project with his focus on Ingolstadt Smart City initiative in collaboration with Audi.
-
Natasha Iqbal
The writer is an undergrad in philosophy and business from the University of Kent. She likes to write on culture and current affairs.
